Dutch-based Plasmacure raises €6M to help treat complex wounds; also secures €8.5M+ US go-to-market financing
Nijmegen, the Netherlands-based Plasmacure, a developer of the PLASOMA cold plasma system for complex wound treatment, has secured €6M funding in a Series A investment from a strategic consortium led by U.S.-based Venture Medical.